FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.5  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Durogesic DTrans 12 transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 25 transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 50 transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 75 transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 100 transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 25 patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 25 patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Conti patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Waymade Healthcare Plc) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12 transdermal patches (Lexon (UK) Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 25 transdermal patches (Lexon (UK) Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 50 transdermal patches (Lexon (UK) Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 75 transdermal patches (Lexon (UK) Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 100 transdermal patches (Lexon (UK) Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 25 patches (Lexon (UK) Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 25 patches (Lexon (UK) Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Conti patches (Lexon (UK) Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (Lexon (UK) Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Lexon (UK) Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Lexon (UK) Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 5mg/24hours transdermal patches (Special Order) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Androderm 5mg/24hours transdermal patches (Imported (United States)) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 5mg/24hours transdermal patches 1 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 5mg/24hours transdermal patches (Special Order) 1 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Androderm 5mg/24hours transdermal patches (Imported (United States)) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 25mg/16hours transdermal patches 14 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette invisi 25mg/16hours patches (McNeil Products Ltd) 14 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Hyoscine 1mg/72hours transdermal patches 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Scopoderm TTS 1.5mg patches (Novartis Consumer Health UK Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour transdermal patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour transdermal patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour transdermal patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour patches 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour patches 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour patches 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour patches 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour patches 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour patches 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour transdermal patches 3 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour transdermal patches 6 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour transdermal patches 3 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour transdermal patches 6 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour transdermal patches 3 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour transdermal patches 6 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Lexon (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Waymade Healthcare Plc) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Waymade Healthcare Plc) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Waymade Healthcare Plc) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Sigma Pharmaceuticals Plc) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Waymade Healthcare Plc) 3 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Waymade Healthcare Plc) 6 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Waymade Healthcare Plc) 3 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Waymade Healthcare Plc) 6 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Waymade Healthcare Plc) 3 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Waymade Healthcare Plc) 6 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Waymade Healthcare Plc) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Waymade Healthcare Plc) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Waymade Healthcare Plc) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 3 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 3 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Lexon (UK) Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Lexon (UK) Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Lexon (UK) Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
NiQuitin Pre-Quit Clear 21mg patches (GlaxoSmithKline Consumer Healthcare) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Start Previous Page 15 of 21 Next End

This concept is not in any reference sets

Back to Start